Post RFQ
Produced via multiple recrystallization and purification processes, this product meets the strict purity standards of the United States Pharmacopeia (USP), European Pharmacopoeia (EP) and British Pharmacopoeia (BP). Its heavy metal levels are 50% below the maximum allowed limits in global pharmaceutical standards, with no detectable residual solvents that could impact drug stability. The uniform fine particle size ensures even distribution throughout pharmaceutical formulations, improving production yield and product consistency.

This product appears as a white, fine powder with an average particle size of 150 mesh and a melting point of 70-71℃. It is packaged in food-grade aluminum foil bags enclosed in rigid cardboard drums for maximum protection against moisture and contamination. It must be stored in a cool, dry environment with controlled humidity, and complies with ICH Q7a Good Manufacturing Practice guidelines for pharmaceutical excipients.

It is primarily used as a lubricant in tablet and capsule manufacturing to reduce sticking to press molds and improve the surface finish of finished dosage forms. It also acts as a thickening agent for topical ointments and creams, adjusting the texture and spreadability of skincare and pharmaceutical topical products. Target customers include oral solid dosage manufacturers, topical pharmaceutical producers and CDMO facilities.